Humacyte (HUMA) Gross Profit (2025 - 2026)
Humacyte (HUMA) reported Gross Profit of -$1.5 million for Q1 2026, down 517.03% year-over-year from $370000.0 in Q1 2025, and up 82.09% quarter-over-quarter from -$8.6 million in Q4 2025.
Humacyte (HUMA) Gross Profit (2025 - 2026) Analysis & Trends
Humacyte (HUMA) has 2 years of Gross Profit data on file, last reported at -$1.5 million in Q1 2026.
- Gross Profit for Q1 2026 came in at -$1.5 million, down 517.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.6 million (down 2688.38% YoY), and the FY2025 annual result was -$7.7 million, changed N/A from the prior year.
- Gross Profit improved to -$1.5 million in Q1 2026 per HUMA's latest filing, from -$8.6 million in the prior quarter.
- Over five years, Gross Profit peaked at $493000.0 in Q3 2025 and troughed at -$8.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.54 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Dec 31, 2025 | -8.62 Mn |
| Dec 31, 2025 | -8.62 Mn |
| Sep 30, 2025 | 493,000.00 |
| Sep 30, 2025 | 493,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Mar 31, 2025 | 370,000.00 |